-
公开(公告)号:WO2003037853A1
公开(公告)日:2003-05-08
申请号:PCT/US2002/034188
申请日:2002-10-25
Applicant: CEPHALON, INC.
Inventor: BACON, Edward, R. , CHATTERJEE, Sankar , DUNN, Derek , MALLAMO, John, P. , MILLER, Matthew, S. , TRIPATHY, Rabindranath , VAUGHT, Jeffry, L.
IPC: C07C317/44
CPC classification number: C07D263/34 , C07C317/44 , C07C323/60 , C07C323/63 , C07C2603/18 , C07C2603/32 , C07D207/16 , C07D207/273 , C07D207/416 , C07D211/88 , C07D213/34 , C07D219/04 , C07D231/54 , C07D233/64 , C07D261/08 , C07D263/16 , C07D263/32 , C07D275/02 , C07D277/26 , C07D277/56 , C07D307/68 , C07D311/84 , C07D333/18 , C07D335/14 , C07D409/12 , C07D409/14 , C07D413/14 , C07D417/06 , C07D495/04
Abstract: The present invention is directed to chemical compositions of substituted thioacetamides, processes for the preparation thereof and uses of the compositions in the treatment of diseases.
Abstract translation: 本发明涉及取代的硫代乙酰胺的化学组成,其制备方法和组合物在治疗疾病中的用途。
-
12.PHENYL SUBSTITUTED 5-MEMBERED NITROGEN CONTAINING HETEROCYCLES FOR THE TREATMENT OF OBESITY 审中-公开
Title translation: 用于治疗肥胖的PHENYL取代的含有5个成员的含氮化合物公开(公告)号:WO2003037332A1
公开(公告)日:2003-05-08
申请号:PCT/US2002/032895
申请日:2002-10-15
Applicant: BAYER CORPORATION , COISH, Philip, D., G. , O'CONNOR, Stephen, J. , WICKENS, Philip , ZHANG, Chengzhi , ZHANG, Hai-Jun
Inventor: COISH, Philip, D., G. , O'CONNOR, Stephen, J. , WICKENS, Philip , ZHANG, Chengzhi , ZHANG, Hai-Jun
IPC: A61K31/426
CPC classification number: C07D263/34 , C07D231/22 , C07D233/64 , C07D233/88 , C07D233/90 , C07D249/10 , C07D277/26 , C07D277/56 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/06 , C07D403/12 , C07D405/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D471/04 , C07D471/10
Abstract: This invention relates to novel heterocyclic compounds, compositions, and methods for treating or preventing obesity and obesity-related diseases.
Abstract translation: 本发明涉及用于治疗或预防肥胖和肥胖相关疾病的新型杂环化合物,组合物和方法。
-
13.THIAZOLE DERIVATIVES FOR TREATING PPAR RELATED DISORDERS 审中-公开
Title translation: 用于治疗PPAR相关疾病的噻唑衍生物公开(公告)号:WO2002062774A1
公开(公告)日:2002-08-15
申请号:PCT/US2001/049230
申请日:2001-12-19
Applicant: GLAXO GROUP LIMITED , CADILLA, Rodolfo , GOSMINI, Romain, Luc, Marie , LAMBERT, Millard, Hurst, III , SIERRA, Michael, Lawrence
Inventor: CADILLA, Rodolfo , GOSMINI, Romain, Luc, Marie , LAMBERT, Millard, Hurst, III , SIERRA, Michael, Lawrence
IPC: C07D277/26
CPC classification number: C07D277/24 , C07D277/26
Abstract: The present invention provides compounds of formula (I). These compounds are used for the treatment of PPAR related diseases.
Abstract translation: 本发明提供式(I)化合物。 这些化合物用于治疗PPAR相关疾病。
-
14.THIAZOLE DERIVATIVES USEFUL AS SELECTIVE INHIBITORS OF PDE-IV 审中-公开
Title translation: 噻唑衍生物可用作PDE-IV的选择性抑制剂公开(公告)号:WO1998008830A1
公开(公告)日:1998-03-05
申请号:PCT/EP1997004422
申请日:1997-08-13
Inventor: BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH , AMSCHLER, Hermann , MARTIN, Thomas , FLOCKERZI, Dieter , GUTTERER, Beate , THIBAUT, Ulrich , HATZELMANN, Armin , BOSS, Hildegard , HÄFNER, Dietrich , KLEY, Hans-Peter , BEUME, Rolf
IPC: C07D277/24
CPC classification number: C07D417/04 , C07D277/24 , C07D277/26 , C07D277/30 , C07D417/06
Abstract: Compounds having the formula (I), in which R1, R2, R3, R4 and n have the meanings given in the description, are new effective bronchotherapeutic agents.
Abstract translation: 其中R 1,R 2,R 3,R 4和n具有在说明书中给出的含义的式(I)化合物是新的活性支气管疗法。
-
15.SUBSTITUTED THIAZOLES FOR THE TREATMENT OF INFLAMMATION 审中-公开
Title translation: 用于治疗炎症的替代治疗的THIAZOLES公开(公告)号:WO1996003392A1
公开(公告)日:1996-02-08
申请号:PCT/US1995009444
申请日:1995-07-26
Applicant: G.D. SEARLE & CO. , TALLEY, John, J. , CARTER, Jeffery, S. , COLLINS, Paul, W. , KRAMER, Steven, W. , PENNING, Thomas, D. , ROGIER, Donald, J., Jr. , ROGERS, Roland, S.
Inventor: G.D. SEARLE & CO.
IPC: C07D277/26
CPC classification number: C07D417/04 , C07D277/26 , C07D277/30 , C07D277/42 , C07D277/56 , C07D417/12
Abstract: A class of substituted thiazolyl compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula (II), wherein R is selected from alkyl and amino, wherein R is selected from aryl, cycloalkyl, cycloalkenyl and heterocyclic; wherein R is optionally substituted at a substitutable position with one or more radicals selected from halo, alkylthio, alkylsulfinyl, alkylsulfonyl, haloalkylsulfonyl, aminosulfonyl, alkyl, alkenyl, alkynyl, cyano, carboxyl, carboxyalkyl, alkoxycarbonyl, aminocarbonyl, acyl, N-alkylaminocarbonyl, N-arylaminocarbonyl, N,N-dialkylaminocarbonyl, N-alkyl-N-arylaminocarbonyl, haloalkyl, hydroxyl, alkoxy, hydroxyalkyl, haloalkoxy, amino, N-alkylamino, N,N-dialkylamino, heterocyclic and nitro; and wherein R is selected from halo, amino, alkoxy, nitro, hydroxyl, aminocarbonyl, acyl, alkylaminocarbonyl, arylaminocarbonyl, alkenyl, alkynyl, haloalkoxy, alkylamino, arylamino, aralkylamino, alkoxycarbonylalkyl, alkylaminoalkyl, heterocycloalkyl, aralkyl, cyanoalkyl, N-alkylsulfonylamino, heteroarylsulfonylalkyl, heteroarylsulfonylhaloalkyl, aryloxyalkyl, aralkyloxyalkyl, aryl and heterocyclo, wherein the aryl and heterocyclo radicals are optionally substituted at a substitutable position with one or more radicals selected from halo, alkyl, alkoxy, alkylthio, alkylsulfinyl, haloalkyl, haloalkoxy, carboxyalkyl, alkoxycarbonyl, aminocarbonyl, amino, acyl and alkylamino; or a pharmaceutically-acceptable salt thereof.
Abstract translation: 描述了一类用于治疗炎症和炎症相关疾病的取代的噻唑基化合物。 特别感兴趣的化合物由式(II)定义,其中R 4选自烷基和氨基,其中R 5选自芳基,环烷基,环烯基和杂环; 其中R 5任选在可取代的位置被一个或多个选自卤素,烷硫基,烷基亚磺酰基,烷基磺酰基,卤代烷基磺酰基,氨基磺酰基,烷基,烯基,炔基,氰基,羧基,羧基烷基,烷氧基羰基,氨基羰基,酰基,N 烷基氨基羰基,N-芳基氨基羰基,N,N-二烷基氨基羰基,N-烷基-N-芳基氨基羰基,卤代烷基,羟基,烷氧基,羟基烷基,卤代烷氧基,氨基,N-烷基氨基,N,N-二烷基氨基,杂环和硝基。 其中R 6选自卤素,氨基,烷氧基,硝基,羟基,氨基羰基,酰基,烷基氨基羰基,芳基氨基羰基,烯基,炔基,卤代烷氧基,烷基氨基,芳基氨基,芳烷基氨基,烷氧基羰基烷基,烷基氨基烷基,杂环烷基,芳烷基,氰基烷基,N - 烷基磺酰基氨基,杂芳基磺酰基烷基,杂芳基磺酰基卤代烷基,芳氧基烷基,芳烷氧基烷基,芳基和杂环,其中芳基和杂环基任选在可取代位置与一个或多个选自卤素,烷基,烷氧基,烷硫基,烷基亚磺酰基,卤代烷基,卤代烷氧基, ,烷氧基羰基,氨基羰基,氨基,酰基和烷基氨基; 或其药学上可接受的盐。
-
16.THIAZOLE-SUBSTITUTED BENZYL ALCOHOLS AS LEUKOTRIENE ANTAGONISTS 审中-公开
Title translation: 噻唑取代苄基醇作为白蛋白拮抗剂公开(公告)号:WO1993021168A1
公开(公告)日:1993-10-28
申请号:PCT/CA1993000146
申请日:1993-04-02
Applicant: MERCK FROSST CANADA INC.
Inventor: MERCK FROSST CANADA INC. , ZAMBONI, Robert , DUFRESNE, Claude , LAU, Cheuk, K.
IPC: C07D277/26
CPC classification number: C07D417/10 , C07D277/24 , C07D277/26 , C07D277/64 , C07D417/12
Abstract: Compounds having formula (I) are antagonists of the actions of leukotrienes. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.
Abstract translation: 具有式(I)的化合物是白三烯作用的拮抗剂。 这些化合物可用作抗哮喘,抗过敏,抗炎和细胞保护剂。 它们也可用于治疗心绞痛,脑痉挛,肾小球肾炎,肝炎,内毒素血症,葡萄膜炎和同种异体移植排斥。
-
17.METABOTROPIC GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATORS (NAMS) AND USES THEREOF 审中-公开
Title translation: 代谢性谷氨酸受体负离子调节因子(NAMS)及其用途公开(公告)号:WO2015191630A1
公开(公告)日:2015-12-17
申请号:PCT/US2015/034964
申请日:2015-06-09
Applicant: SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
IPC: C07D277/20 , C07D417/04 , C07D285/08 , C07D217/06 , C07D249/08 , A61K31/426 , A61K31/427 , A61K31/433 , A61K31/4196
CPC classification number: C07D417/14 , A61K31/4196 , A61K31/426 , A61K31/427 , A61K31/433 , A61K31/505 , A61K31/506 , C07D217/06 , C07D231/12 , C07D233/54 , C07D233/64 , C07D239/26 , C07D243/12 , C07D249/08 , C07D261/08 , C07D263/32 , C07D271/06 , C07D275/02 , C07D277/20 , C07D277/26 , C07D277/30 , C07D285/08 , C07D307/38 , C07D333/24 , C07D401/04 , C07D401/10 , C07D401/12 , C07D401/14 , C07D403/10 , C07D403/12 , C07D405/04 , C07D405/10 , C07D409/02 , C07D409/04 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/10
Abstract: Provided herein are small molecule active metabotropic glutamate subtype-2 and -3 receptor negative allosteric modulators (NAMs), compositions comprising the compounds, and methods of using the compounds and compositions.
Abstract translation: 本文提供的是小分子活性代谢型谷氨酸亚型-2和-3受体负变构调节剂(NAM),包含该化合物的组合物,以及使用该化合物和组合物的方法。
-
公开(公告)号:WO2015134790A1
公开(公告)日:2015-09-11
申请号:PCT/US2015/019032
申请日:2015-03-05
Applicant: SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
Inventor: COSFORD, Nicholas, D.P. , SMITH, Jeffrey , ARDECKY, Robert, J. , ZOU, Jiwen , MATTMANN, Margrith , TERIETE, Peter , LAMBERT, Lester
IPC: A61K31/427 , C07D277/04 , A61K31/5377 , A61K31/18 , A61K31/426 , A61K31/5375
CPC classification number: C07D277/46 , A61K31/426 , A61K31/427 , A61K31/5377 , C07D277/26 , C07D277/40 , C07D277/42 , C07D417/04 , C07D417/12 , Y02A50/385 , Y02A50/387 , Y02A50/393
Abstract: Provided herein are small molecule Fatty Acid Synthase Inhibitors, compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.
Abstract translation: 本文提供了小分子脂肪酸合酶抑制剂,包含该化合物的组合物,以及使用该化合物和包含该化合物的组合物的方法。
-
公开(公告)号:WO2014123203A1
公开(公告)日:2014-08-14
申请号:PCT/JP2014/052803
申请日:2014-02-06
Applicant: 京都薬品工業株式会社
IPC: C07C311/51 , A61K31/341 , A61K31/343 , A61K31/381 , A61K31/395 , A61K31/40 , A61K31/403 , A61K31/415 , A61K31/4155 , A61K31/4184 , A61K31/42 , A61K31/421 , A61K31/4245 , A61K31/426 , A61K31/433 , A61K31/47 , A61K31/50 , A61K31/501 , A61P3/04 , A61P3/06 , A61P3/10 , A61P5/50 , A61P9/10 , A61P29/00 , A61P35/00 , A61P43/00 , C07D207/325 , C07D209/08 , C07D209/42 , C07D209/82 , C07D215/48 , C07D225/02 , C07D231/12 , C07D235/26 , C07D237/14 , C07D261/10 , C07D263/32 , C07D271/06 , C07D277/24 , C07D277/26 , C07D277/64 , C07D285/12 , C07D307/42 , C07D307/85 , C07D333/16 , C07D333/38 , C07D333/76 , C07D403/04 , C07D405/12 , C07D409/12 , C07D417/04
CPC classification number: C07D307/85 , C07C307/06 , C07C311/51 , C07C311/55 , C07C317/44 , C07C323/44 , C07C323/60 , C07C323/67 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2602/08 , C07C2602/30 , C07C2603/18 , C07D207/325 , C07D207/34 , C07D209/08 , C07D209/42 , C07D209/86 , C07D213/32 , C07D213/81 , C07D215/36 , C07D215/48 , C07D215/54 , C07D231/12 , C07D235/26 , C07D237/14 , C07D237/24 , C07D249/06 , C07D261/08 , C07D261/10 , C07D263/32 , C07D263/56 , C07D271/06 , C07D277/24 , C07D277/26 , C07D277/64 , C07D285/12 , C07D295/096 , C07D295/26 , C07D307/38 , C07D307/42 , C07D307/79 , C07D317/56 , C07D319/18 , C07D333/16 , C07D333/18 , C07D333/22 , C07D333/38 , C07D333/76 , C07D403/04 , C07D405/06 , C07D405/12 , C07D409/12 , C07D417/04
Abstract: PTP-1B阻害活性を有し、医薬として優れた化合物またはその医薬上許容される塩の提供。 一般式(I):[式中、各記号は明細書中と同義である。] で表される化合物またはその医薬上許容される塩。
Abstract translation: 提供作为药物优异的具有PTP-1B抑制活性的化合物或其药学上可接受的盐。 通式(I)表示的化合物或其药学上可接受的盐,在式中,各符号表示与说明书相同。
-
公开(公告)号:WO2013157229A1
公开(公告)日:2013-10-24
申请号:PCT/JP2013/002459
申请日:2013-04-11
Applicant: クミアイ化学工業株式会社 , イハラケミカル工業株式会社
IPC: C07C323/20 , A01N41/10 , A01N41/12 , A01N43/08 , A01N43/40 , A01N43/54 , A01N43/56 , A01N43/653 , A01N43/78 , A01P7/02 , A01P7/04 , C07C317/22 , C07C317/46 , C07C323/62 , C07C331/10
CPC classification number: C07C321/28 , A01N31/16 , A01N33/20 , A01N37/10 , A01N37/32 , A01N37/34 , A01N37/38 , A01N39/00 , A01N41/10 , A01N41/12 , A01N43/08 , A01N43/40 , A01N43/50 , A01N43/54 , A01N43/56 , A01N43/653 , A01N43/78 , A01N47/02 , A01N47/48 , A01N55/00 , C07C317/14 , C07C317/22 , C07C317/32 , C07C317/46 , C07C323/12 , C07C323/18 , C07C323/20 , C07C323/25 , C07C323/62 , C07C331/10 , C07D213/34 , C07D231/12 , C07D233/64 , C07D239/26 , C07D249/08 , C07D277/26
Abstract: 【課題】本発明は、優れた有害生物防除効果を有するアルキルフェニルスルフィド誘導体又はその塩、それを有効成分として含有する有害生物防除剤及びその製造中間体を提供する。 【解決手段】一般式[I] [式中、R 1 はC 1 ~C 6 ハロアルキル基等を示し、R 2 はハロゲン原子、C 1 ~C 6 アルキル基等を示し、R 3 は水素原子、ハロゲン原子等を示し、R 4 はC 1 ~C 12 アルキル基等を示す。] で表されるアルキルフェニルスルフィド誘導体又はその農業上許容される塩、それを有効成分として含有する有害生物防除剤及びその製造中間体。
Abstract translation: 本发明提供一种具有优异的害虫防治效果的烷基苯硫醚衍生物或其盐,含有它们作为活性成分的害虫防治剂及其制备中间体。 [溶液]通式[I]表示的烷基苯硫基衍生物:[式中,R1表示C1-C6卤代烷基等,R2表示卤素原子,C1-C6烷基等,R3表示 氢原子,卤素原子等,R 4表示C 1〜C 12烷基等]或其农业上可接受的盐,含有活性成分的害虫防治剂及其制造中间体。
-
-
-
-
-
-
-
-
-